Expression and significance of COX-2, bcl-2, Caspase-3 in diffuse large B-cell lymphoma

Journal of Leukemia and Lymphoma

Volumn 18, Issue 4, 2009, Pages 223-225

  Li, Jie ^a   Hao, Hong Ling ^a   Xue, Li Ying ^a   Wang, Chao ^a   Wang, Su Yun ^a   Wang, Rui Cang ^a  

^a HEBEI GENERAL HOSPITAL   (China)

Author keywords

Bcl 2; Caspase 3; Cyclooxygenase 2; Diffuse; Genes; Large cell; Lymphoma

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; PROTEIN BCL 2;

ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CLINICAL ARTICLE; CORRELATIONAL STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOID TISSUE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 66349127390     PISSN: 10099921     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.l009-9921.2009.04.012     Document Type: Article

References (14)

1. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2: a molecula target for cancer prevention and treatment. Trends Pharmacol Sci, 2003,24:96-102.
2. Chhanabhai M, Krajewski S, Krajewska M, et al. Immunohistochemical analysis of interleukin-1 β -converting enzyme/Ced-3 family protease, CPP32/caspase23, in Hodgkin's disease. Blood, 1997, 90: 2451-2455.
3. Jaffe ES, Harris NL, Stein H, et al, World Health Organization classification of tumours pathology and genetics of haemotopoietic and lymphoid tissue. Lyon: IARC Press, 2001.
4. Singh B, Lucci A. Role of cyclooxygenase-2 in breast cancer. J Surg Res, 2002,108: 173-179.
5. Souza RF, Shewmake K, Beer DG, et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res, 2000, 60: 5767-5772.
6. Richter M, Weiss M, Weinberger I, et al. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis, 2001, 22: 17-25.
7. Rosenberg L, Louik C , Shapiro S. Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. Cancer, 1998, 82: 2326-2333.
8. Harris MH, Thompson CB. The role of the bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ, 2000, 7: 1182-1191.
9. Chinese source
10. Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 1998,58:362-366.
11. Shimizu D, Vallbohmer D , Kuramochi H, et al. Increasing cyclooxygenase-2 (COX-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of bcl-2. Int J Cancer, 2006, 119: 765-770.
12. Sun Y, TangXM, HalfE, etal. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res, 2002,62:6323-6328.
13. Chan TA, Morin PJ, Vogelstein B, et al. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA, 1998,95:681-686.
14. Swanton E, Savory P, Cosulich S, et al. Bcl-2 regulates a caspase-3/caspase-2 apoptotic cascade in cytosolic extracts. Oncogene, 1999,18: 1781-1787.